Navigation Links
Free Plan B Faces Controversy

Plan B is the name tagged to the new emergency contraceptive pill (ECP) that was approved by the FDA.// This approval was sanctioned in 1999.ECP also known as 'morning-after-pill' is an oral contraceptive to be taken immediately after intercourse to avoid an unwanted pregnancy.

It consists of pills containing levonorgestrel or also called progesterone only pills. Other pills with a combination of oetrogen and progesterone as well have been approved by the FDA. They act by preventing ovulation or delaying transport of sperms, and by inhibiting implantation.

This summer the FDA sanctioned the sale of Plan B across the counter as a contraceptive measure for women who are 18 or older. This has raised an uproar from many quarters. Since Plan B ECP contains a very high percentage of hormones, its safety has been questioned. It is to be taken, only after an incidence of unprotected sex, sexual assault or following contraceptive failure.

Planned Parenthood Clinics across the U.S buys ECP from Barr Laboratories, the manufacturer of Plan B, at preferentially discounted rates. Planned Parenthood then distributes these ECP for free in an effort to educate the public. This has made many organizations aghast, as they feel that this may trigger more risky sexual behavior, involving multiple partners, increased instances of teenage sex, and sexually transmitted diseases.

Concerned Women for America, Iowa Right to Life, and the Iowa Christian Alliance asked members to acquire free doses of Plan B and then destroy it. A small percentage of such free doses were reportedly destroyed in Iowa. Plan B packages cost about $35-$45 per dose.


MST
'"/>




Page: 1

Related medicine news :

1. Women With High Oestrogen Levels Have Prettier Faces
2. Gynaecologist Faces Stiff Prison Sentence On Counts Of Sexual Abuse
3. NHS Dentistry Faces Pensioners’ Delug
4. Zimbabwe Faces Shortage Of AIDS Drugs
5. Delhi Faces Flu Threat Due To Change In Weather
6. Government Advertisement Faces Criticism For Wrong Salt Claim
7. Famous Faces Join Campaign To Spread Awareness On Ovarian Cancer
8. Ovarian Cancer Research Faces Funds Crunch
9. Delhi Faces Threat of Brain Fever
10. Dr Death Faces Malpractice Case In Australia
11. Britains Bird Flu Contingency Plans Faces Criticism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San ... Society and the Road To Recovery® program to drive cancer patients to and from ... adults to ensure the highest quality of life and ongoing independence. Getting to ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: